Special considerations for therapeutic choice of non-vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation

Ken Okumura; Masatsugu Hori; Norio Tanahashi; A. John Camm

doi:10.1002/clc.22596

Special considerations for therapeutic choice of non-vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation

Clinical Cardiology ◽

10.1002/clc.22596 ◽

2016 ◽

Vol 40 (2) ◽

pp. 126-131 ◽

Cited By ~ 9

Author(s):

Ken Okumura ◽

Masatsugu Hori ◽

Norio Tanahashi ◽

A. John Camm

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Oral Anticoagulants ◽

Japanese Patients ◽

Vitamin K Antagonist ◽

Nonvalvular Atrial Fibrillation ◽

Therapeutic Choice

Download Full-text

Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity

Advances in Therapy ◽

10.1007/s12325-021-01724-8 ◽

2021 ◽

Author(s):

Steven Deitelzweig ◽

Allison Keshishian ◽

Amiee Kang ◽

Amol D. Dhamane ◽

Xuemei Luo ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Nonvalvular Atrial Fibrillation

Download Full-text

Effect of Renal Function on Dosing of Non–Vitamin K Antagonist Direct Oral Anticoagulants Among Patients With Nonvalvular Atrial Fibrillation

Annals of Pharmacotherapy ◽

10.1177/1060028017728295 ◽

2017 ◽

Vol 52 (2) ◽

pp. 147-153 ◽

Cited By ~ 6

Author(s):

Sulena Shrestha ◽

Onur Baser ◽

Winghan Jacqueline Kwong

Keyword(s):

Atrial Fibrillation ◽

Renal Function ◽

Vitamin K ◽

Oral Anticoagulants ◽

Direct Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Nonvalvular Atrial Fibrillation

Download Full-text

Renal Function and Treatment Persistence with Non-Vitamin K Antagonist Oral Anticoagulants in Japanese Patients with Atrial Fibrillation: A Single-Center Experience

Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ◽

10.3999/jscpt.47.115 ◽

2016 ◽

Vol 47 (3) ◽

pp. 115-122

Author(s):

Miyoko NAGANUMA ◽

Tsuyoshi SHIGA ◽

Takehiko NAGAO ◽

Kenji MARUYAMA ◽

Atsushi SUZUKI ◽

...

Keyword(s):

Atrial Fibrillation ◽

Renal Function ◽

Vitamin K ◽

Oral Anticoagulants ◽

Japanese Patients ◽

Vitamin K Antagonist ◽

Single Center ◽

Treatment Persistence ◽

Single Center Experience

Download Full-text

PRM20 - CLINICAL EFFECTIVENESS AND SAFETY OF STANDARD-DOSE AND LOW-DOSE NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: A NATIONWIDE POPULATION-BASED COHORT STUDY

Value in Health ◽

10.1016/j.jval.2018.09.2144 ◽

2018 ◽

Vol 21 ◽

pp. S359

Author(s):

JE Yun

Keyword(s):

Atrial Fibrillation ◽

Cohort Study ◽

Vitamin K ◽

Low Dose ◽

Standard Dose ◽

Oral Anticoagulants ◽

Clinical Effectiveness ◽

Population Based ◽

Vitamin K Antagonist ◽

Nonvalvular Atrial Fibrillation

Download Full-text

CORRIGENDUM: Use of Oral Anticoagulants According to the Degree of Renal Impairment in Japanese Patients With Atrial Fibrillation　– Which Non-Vitamin K Antagonist Oral Anticoagulant to Select? –

Circulation Journal ◽

10.1253/circj.cj-66-0129 ◽

2016 ◽

Vol 80 (3) ◽

pp. 777

Author(s):

Takanori Ikeda

Keyword(s):

Atrial Fibrillation ◽

Renal Impairment ◽

Vitamin K ◽

Oral Anticoagulant ◽

Oral Anticoagulants ◽

Japanese Patients ◽

Vitamin K Antagonist

Download Full-text

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation

Circulation Journal ◽

10.1253/circj.cj-14-1042 ◽

2015 ◽

Vol 79 (2) ◽

pp. 339-345 ◽

Cited By ~ 30

Author(s):

Keitaro Senoo ◽

Yee Cheng Lau ◽

Mikhail Dzeshka ◽

Deirdre Lane ◽

Ken Okumura ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Oral Anticoagulants ◽

Japanese Patients ◽

Vitamin K Antagonist ◽

Efficacy And Safety

Download Full-text

Protocol for Cerebral Microbleeds during the Non–Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial

Journal of Stroke and Cerebrovascular Diseases ◽

10.1016/j.jstrokecerebrovasdis.2015.05.032 ◽

2015 ◽

Vol 24 (9) ◽

pp. 2143-2148 ◽

Cited By ~ 9

Author(s):

Shunya Takizawa ◽

Fumiaki Tanaka ◽

Kazutoshi Nishiyama ◽

Yasuhiro Hasegawa ◽

Eiichiro Nagata ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Warfarin Therapy ◽

Oral Anticoagulants ◽

Pilot Trial ◽

Vitamin K Antagonist ◽

Cerebral Microbleeds ◽

Stroke Patients ◽

Nonvalvular Atrial Fibrillation

Download Full-text

Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies

European Journal of Epidemiology ◽

10.1007/s10654-018-0415-7 ◽

2018 ◽

Vol 34 (2) ◽

pp. 173-190 ◽

Cited By ~ 18

Author(s):

Guowei Li ◽

Gregory Y. H. Lip ◽

Anne Holbrook ◽

Yaping Chang ◽

Torben B. Larsen ◽

...

Keyword(s):

Atrial Fibrillation ◽

Systematic Review ◽

Vitamin K ◽

Stroke Prevention ◽

Comparative Effectiveness ◽

Observational Studies ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Nonvalvular Atrial Fibrillation

Download Full-text

Beneficial Effect of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation　– Results of the J-RHYTHM Registry 2 –

Circulation Journal ◽

10.1253/circj.cj-16-0066 ◽

2016 ◽

Vol 80 (4) ◽

pp. 843-851 ◽

Cited By ~ 35

Author(s):

Eitaro Kodani ◽

Hirotsugu Atarashi ◽

Hiroshi Inoue ◽

Ken Okumura ◽

Takeshi Yamashita ◽

...

Keyword(s):

Atrial Fibrillation ◽

Beneficial Effect ◽

Vitamin K ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Nonvalvular Atrial Fibrillation

Download Full-text

Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice

Drugs ◽

10.1007/s40265-015-0405-y ◽

2015 ◽

Vol 75 (9) ◽

pp. 979-998 ◽

Cited By ~ 7

Author(s):

Julie Kalabalik ◽

Gail B. Rattinger ◽

Jesse Sullivan ◽

Malgorzata Slugocki ◽

Antonia Carbone ◽

...

Keyword(s):

Atrial Fibrillation ◽

Clinical Practice ◽

Vitamin K ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Review Of The Literature ◽

Nonvalvular Atrial Fibrillation ◽

Special Patient

Download Full-text

Special considerations for therapeutic choice of non-vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation

Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity

Effect of Renal Function on Dosing of Non–Vitamin K Antagonist Direct Oral Anticoagulants Among Patients With Nonvalvular Atrial Fibrillation

Renal Function and Treatment Persistence with Non-Vitamin K Antagonist Oral Anticoagulants in Japanese Patients with Atrial Fibrillation: A Single-Center Experience

PRM20 - CLINICAL EFFECTIVENESS AND SAFETY OF STANDARD-DOSE AND LOW-DOSE NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: A NATIONWIDE POPULATION-BASED COHORT STUDY

CORRIGENDUM: Use of Oral Anticoagulants According to the Degree of Renal Impairment in Japanese Patients With Atrial Fibrillation – Which Non-Vitamin K Antagonist Oral Anticoagulant to Select? –

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation

Protocol for Cerebral Microbleeds during the Non–Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial

Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies

Beneficial Effect of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation – Results of the J-RHYTHM Registry 2 –

Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice

CORRIGENDUM: Use of Oral Anticoagulants According to the Degree of Renal Impairment in Japanese Patients With Atrial Fibrillation　– Which Non-Vitamin K Antagonist Oral Anticoagulant to Select? –

Beneficial Effect of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation　– Results of the J-RHYTHM Registry 2 –